|
Volumn 142, Issue 5, 2003, Pages 214-219
|
Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex
a a |
Author keywords
Ciprofloxacin; Complexation; Diffractometry; DSC; FTIR; Hydroxypropyl cyclodextrin; Ophthalmic formulation; Pharmacological properties; Physicochemical properties; SEM; X ray
|
Indexed keywords
2 HYDROXYPROPYL BETA CYCLODEXTRIN;
CIPROFLOXACIN;
EYE DROPS;
ANIMAL EXPERIMENT;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
DENSITY;
DIFFERENTIAL SCANNING CALORIMETRY;
DRUG FORMULATION;
DRUG SOLUBILITY;
DRUG STABILITY;
ESCHERICHIA COLI;
EYE IRRITATION;
FREEZE DRYING;
INFRARED SPECTROSCOPY;
NONHUMAN;
PH;
RABBIT;
REFRACTION INDEX;
SCANNING ELECTRON MICROSCOPY;
STAPHYLOCOCCUS AUREUS;
SURFACE TENSION;
VISCOSITY;
X RAY POWDER DIFFRACTION;
ANTI-INFECTIVE AGENTS;
BETA-CYCLODEXTRINS;
CALORIMETRY, DIFFERENTIAL SCANNING;
CHEMISTRY, PHYSICAL;
CIPROFLOXACIN;
CYCLODEXTRINS;
DRUG CARRIERS;
DRUG STABILITY;
MICROSCOPY, ELECTRON, SCANNING;
OPHTHALMIC SOLUTIONS;
SPECTROSCOPY, FOURIER TRANSFORM INFRARED;
X-RAY DIFFRACTION;
|
EID: 0141756238
PISSN: 00066648
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (7)
|